Indeed, it could reduce secondary bile acid (DCA, LCA) synthesis and promote the intestinal FXR–FGF15 axis, a pathway that plays an important role in the regulation of host metabolism, potentially inhibiting progression from MASLD to HCC [52]. Here, NR1H4 is linked to hepatocellular carcinoma.